ArticleCancer letters2018

DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.

Yunxiao Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.